Modifiable Factors and 10‐Year and Lifetime Risk of Cardiovascular Disease in Adults With New‐Onset Diabetes: The Kailuan Cohort Study
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.041223 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Shouling Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Kailuan General Hospital Tangshan China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Risk Reduction Behavior. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Adults with newly diagnosed diabetes are at elevated risk of cardiovascular disease (CVD). However, the extent to which optimizing modifiable lifestyle and clinical factors can mitigate this risk remains insufficiently assessed across both short‐ and long‐term risk periods.
Methods
This study analyzed 12 222 participants from the Kailuan cohort (2006–2016) who developed new‐onset diabetes and were free of baseline CVD. Modifiable risk factors were assessed using the Life's Essential 8 algorithm, including physical activity, nicotine exposure, dietary health, sleep duration, body mass index, blood pressure, blood glucose, and lipid levels. Participants were followed through 2020 for CVD incidence. Ten‐year and lifetime (ages 25–85) CVD risks were estimated using Fine–Gray competing risks models.
Results
During a median follow‐up of 7.6 years, 1371 participants experienced CVD events. Only 7.3% of individuals had ≥4 modifiable risk factors at favorable levels at baseline. The 10‐year CVD risk decreased from 16.01% to 6.11% as favorable factors increased from ≤1 to ≥4; lifetime CVD risk declined from 55.16% to 26.70%. After adjusting for unmodifiable covariates, participants with 2, 3, and ≥4 favorable factors had 13% (hazard ratio [HR], 0.87 [95% CI, 0.77–0.98]), 31% (HR, 0.69 [95% CI, 0.59–0.80]), and 65% (HR, 0.35 [95% CI, 0.26–0.47]) lower 10‐year CVD risks, respectively, compared with those with ≤1 favorable factor. Lifetime CVD risk reductions were 9% (HR, 0.91 [95% CI, 0.81–1.03]), 27% (HR, 0.73 [95% CI, 0.62–0.85]), and 61% (HR, 0.39 [95% CI, 0.29–0.52]), respectively.
Conclusions
Improving modifiable risk factors is associated with reduced short‐ and long‐term CVD risk in adults with new‐onset diabetes, underscoring the importance of proactive lifestyle interventions in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology Kailuan General Hospital Tangshan China.
- School of Public Health Hainan Medical University Haikou China.
- Department of Cardiology The Second Affiliated Hospital of Harbin Medical University Harbin China.
- Heilongjiang Provincial Key Laboratory of Panvascular Disease, The Second Affiliated Hospital of Harbin Medical University Harbin China.
- Zunhua Minzu Hospital Tangshan China.
ORCID-Profile: Shouling Wu, Yuntao Wu, Yi Ning, Xiang Peng, Haiyan Zhao, Jun Feng, Liming Lin, Shuohua Chen, Jinwei Tian, Cheng Jin
Zitieren
APA
Wu, S., Wu, Y., Ning, Y., Peng, X., Zhao, H., Feng, J., Lin, L., Ruan, C., Chen, S., Tian, J., & Jin, C. (2025). Modifiable Factors and 10‐Year and Lifetime Risk of Cardiovascular Disease in Adults With New‐Onset Diabetes: The Kailuan Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.041223
Vancouver
Wu S, Wu Y, Ning Y, Peng X, Zhao H, Feng J, et al. Modifiable Factors and 10‐Year and Lifetime Risk of Cardiovascular Disease in Adults With New‐Onset Diabetes: The Kailuan Cohort Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.041223
BibTeX
@article{Wu2025,
author = {Wu, Shouling and Wu, Yuntao and Ning, Yi and Peng, Xiang and Zhao, Haiyan and Feng, Jun and Lin, Liming and Ruan, Chunyu and Chen, Shuohua and Tian, Jinwei and Jin, Cheng},
title = {Modifiable Factors and 10‐Year and Lifetime Risk of Cardiovascular Disease in Adults With New‐Onset Diabetes: The Kailuan Cohort Study},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.041223}
}
EUVIMED